Paper6609729
Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation.
Anderson KC and 5 others. Blood, 1984. Cited by 680 papers, by iCite.
Cite this record
ConductScience Library. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Papers, record 6609729. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6609729
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Surface | Major topic |
| B-Lymphocytes | Major topic |
| Leukemia | Major topic |
| Lymphoma | Major topic |
| Antibodies, Monoclonal | |
| Antigens, Neoplasm | |
| Cell Differentiation | |
| Humans | |
| Phenotype |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 19589 | NCI NIH HHS | United States | P01CA019589 | PubMed and NIH | NIH RePORTER |
| CA 25369 | NCI NIH HHS | United States | R01CA025369 | PubMed and NIH | NIH RePORTER |
Cited by154
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 680 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42129915 | CD20-directed antibody-drug conjugates in non-hodgkin lymphoma: translating preclinical promise into clinical reality. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/42129915 | PubMed |
| 42023212 | CD19-negative relapse after CAR-T cell therapy: mechanisms of antigen escape and lineage switch. | Front Immunol | 2026 | https://conductscience.org/library/papers/42023212 | PubMed |
| 40162108 | CD19 Expression in B-Cell Lymphomas and Clinical Considerations in the Evolving Landscape of CD19-Targeted Therapy. | World J Oncol | 2025 | https://conductscience.org/library/papers/40162108 | PubMed |
| 40097629 | The protective and chemotherapeutical role of amygdalin in induced mammary cancer in experimental mice and upregulation of related genes. | Sci Rep | 2025 | https://conductscience.org/library/papers/40097629 | PubMed |
| 39868594 | CD20 and CD19 promote proliferation driven by the IgM-TLR9-L265P MyD88 complex. | Int Immunol | 2025 | https://conductscience.org/library/papers/39868594 | PubMed |
| 38953025 | Causal role of immune cells in thyroid cancer: a bidirectional Mendelian randomization study. | Front Immunol | 2024 | https://conductscience.org/library/papers/38953025 | PubMed |
| 38650785 | Pyrexia of Unknown Origin Caused by Non-Hodgkin's Lymphoma: A Diagnostic Challenge for Clinicians. | Cureus | 2024 | https://conductscience.org/library/papers/38650785 | PubMed |
| 37692863 | Harnessing the Immune System: An Effective Way to Manage Diffuse Large B-Cell Lymphoma. | J Hematol | 2023 | https://conductscience.org/library/papers/37692863 | PubMed |
| 37654973 | Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions. | Mol Ther Oncolytics | 2023 | https://conductscience.org/library/papers/37654973 | PubMed |
| 36942068 | Computational and Experimental Evaluation of Linker Peptides and Thioredoxin Fusion Tag in CD20-rituximab Specific Interactions. | Iran J Pharm Res | 2022 | https://conductscience.org/library/papers/36942068 | PubMed |
| 36028884 | Computational analysis of 4-1BB-induced NFκB signaling suggests improvements to CAR cell design. | Cell Commun Signal | 2022 | https://conductscience.org/library/papers/36028884 | PubMed |
| 35628495 | Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35628495 | PubMed |
| 35247900 | Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma. | Blood Cancer Discov | 2022 | https://conductscience.org/library/papers/35247900 | PubMed |
| 34910301 | Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). | Eur J Immunol | 2021 | https://conductscience.org/library/papers/34910301 | PubMed |
| 34741682 | Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma. | J Cancer Res Clin Oncol | 2022 | https://conductscience.org/library/papers/34741682 | PubMed |
| 34690620 | Implementation of Vaccinomics and In-Silico Approaches to Construct Multimeric Based Vaccine Against Ovarian Cancer. | Int J Pept Res Ther | 2021 | https://conductscience.org/library/papers/34690620 | PubMed |
| 34680368 | Selection of a Nuclease-Resistant RNA Aptamer Targeting CD19. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34680368 | PubMed |
| 34680031 | Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment. | Biomolecules | 2021 | https://conductscience.org/library/papers/34680031 | PubMed |
| 34277836 | CAR T-cell therapy in mature lymphoid malignancies: clinical opportunities and challenges. | Ann Transl Med | 2021 | https://conductscience.org/library/papers/34277836 | PubMed |
| 34179690 | Simultaneous deep generative modeling and clustering of single cell genomic data. | Nat Mach Intell | 2021 | https://conductscience.org/library/papers/34179690 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6609729
GET https://conductscience.org/api/papers/v1/6609729/cited_by?page=2